相关实验视频

Updated: Jun 1, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

通过细胞载体改善瘤性病毒的系统传递

Ziyi Peng¹, Muhammad Kalim¹, Yong Lu¹

¹Houston Methodist Cancer Center/Weill Cornell Medicine, Houston, TX 77030, USA.

Cancer biology & medicine

|January 20, 2025

概括

瘤性病毒疗法 (OVT) 使用病毒向癌细胞,但向固体瘤输送具有挑战性. 正在探索细胞载体,以改善结病毒 (OV) 传递和提高癌症治疗疗效.

科学领域:

在瘤学瘤学.
病毒学病毒学
免疫治疗是一种免疫疗法.

背景情况:

瘤性病毒疗法 (OVT) 通过在癌细胞中选择性地复制瘤性病毒 (OVs),刺激抗瘤免疫反应,显示出对癌症治疗的希望.
在OVT的关键挑战包括不够的瘤特异性向,有限的瘤透和可变的疗效,特别是在复杂的固体瘤微环境中.

研究的目的:

通过使用细胞载体,审查当前增强型病毒 (OV) 传递的策略.
探索细胞载体如何改善瘤微环境中的OV分布,以优化免疫激活和抗瘤效应.

主要方法:

对细胞载体介导传递瘤病毒 (OVs) 的现有研究进行审查.
分析旨在改善OV向,透和在固体瘤中的疗效的策略.

主要成果:

细胞载体显示出在瘤微环境中改善OVs的输送和分布的潜力.
通过细胞载体进行增强的输送可以优化免疫系统的激活,并最大限度地提高抗瘤效果.

结论:

通过细胞载体改善OV传递对于增强型病毒疗法 (OVT) 临床影响至关重要.
需要对细胞载体策略进行进一步的研究,以克服OVT的挑战并改善癌症治疗结果.

关键词:

瘤治疗性病毒疗法蜂运营商的蜂运营商科性病毒病毒.系统的交付系统的交付针对瘤的特定向.

更多相关视频

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...